CME Group Inc (NASDAQ:CME) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC reduced its stake in CME Group Inc (NASDAQ:CME) by 5.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 49,794 shares of the financial services provider’s stock after selling 2,696 shares during the period. SG Americas Securities LLC’s holdings in CME Group were worth $10,523,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Girard Partners LTD. lifted its stake in shares of CME Group by 3.1% in the 2nd quarter. Girard Partners LTD. now owns 4,363 shares of the financial services provider’s stock worth $847,000 after acquiring an additional 130 shares during the period. Prime Capital Investment Advisors LLC lifted its stake in shares of CME Group by 59.5% in the 2nd quarter. Prime Capital Investment Advisors LLC now owns 319 shares of the financial services provider’s stock worth $62,000 after acquiring an additional 119 shares during the period. Doyle Wealth Management acquired a new stake in shares of CME Group in the 2nd quarter worth approximately $58,000. Fox Run Management L.L.C. acquired a new stake in shares of CME Group in the 2nd quarter worth approximately $571,000. Finally, Aperio Group LLC lifted its stake in shares of CME Group by 3.7% in the 2nd quarter. Aperio Group LLC now owns 210,967 shares of the financial services provider’s stock worth $40,951,000 after acquiring an additional 7,573 shares during the period. 84.80% of the stock is owned by institutional investors.

CME stock traded down $0.83 on Friday, hitting $198.17. 1,172,200 shares of the company’s stock traded hands, compared to its average volume of 1,518,595. The stock has a market cap of $70.53 billion, a price-to-earnings ratio of 29.06, a P/E/G ratio of 3.86 and a beta of 0.18. The company has a current ratio of 1.04, a quick ratio of 1.05 and a debt-to-equity ratio of 0.14. The stock has a fifty day moving average of $208.43 and a 200-day moving average of $201.58. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $224.91.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.75 by $0.15. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.27 billion. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The company’s revenue for the quarter was up 41.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.45 EPS. On average, equities research analysts anticipate that CME Group Inc will post 6.91 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Tuesday, December 10th will be given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.51%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio is 43.99%.

A number of brokerages have recently weighed in on CME. ValuEngine lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Wells Fargo & Co upped their price target on shares of CME Group from $200.00 to $205.00 and gave the stock a “market perform” rating in a research note on Thursday, October 31st. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, October 18th. Citigroup upped their price target on shares of CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. Finally, UBS Group reduced their price target on shares of CME Group from $220.00 to $218.00 and set a “neutral” rating for the company in a research note on Thursday, October 31st. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $203.36.

In other CME Group news, Director Daniel R. Glickman sold 500 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $216.01, for a total value of $108,005.00. Following the completion of the sale, the director now directly owns 14,593 shares of the company’s stock, valued at $3,152,233.93. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sean Tully sold 7,200 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the completion of the sale, the insider now directly owns 19,923 shares of the company’s stock, valued at $4,445,418.99. The disclosure for this sale can be found here. Insiders sold 13,636 shares of company stock valued at $3,001,008 over the last three months. Insiders own 1.20% of the company’s stock.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Death Cross

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.